CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $294,000 | -17.6% | 125,991 | +0.3% | 0.00% | 0.0% |
Q4 2017 | $357,000 | -16.0% | 125,566 | -15.5% | 0.00% | 0.0% |
Q3 2017 | $425,000 | +16.4% | 148,623 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $365,000 | -33.5% | 147,663 | -3.0% | 0.00% | 0.0% |
Q1 2017 | $549,000 | +19.1% | 152,211 | +17.0% | 0.00% | 0.0% |
Q4 2016 | $461,000 | -22.9% | 130,092 | -12.2% | 0.00% | -50.0% |
Q3 2016 | $598,000 | -3.1% | 148,109 | +5.3% | 0.00% | 0.0% |
Q2 2016 | $617,000 | +35.3% | 140,609 | +16.7% | 0.00% | +100.0% |
Q1 2016 | $456,000 | -73.2% | 120,533 | +11.2% | 0.00% | -80.0% |
Q4 2015 | $1,700,000 | +56.1% | 108,426 | +4.9% | 0.01% | +25.0% |
Q3 2015 | $1,089,000 | -59.6% | 103,316 | -3.3% | 0.00% | -55.6% |
Q2 2015 | $2,695,000 | -5.3% | 106,856 | +4.7% | 0.01% | +12.5% |
Q1 2015 | $2,845,000 | +75.0% | 102,086 | +14.6% | 0.01% | +60.0% |
Q4 2014 | $1,626,000 | +50.4% | 89,076 | +6.8% | 0.01% | +66.7% |
Q3 2014 | $1,081,000 | -26.8% | 83,421 | -7.8% | 0.00% | -25.0% |
Q2 2014 | $1,476,000 | -11.4% | 90,461 | -4.0% | 0.00% | -20.0% |
Q1 2014 | $1,665,000 | -27.9% | 94,236 | -1.1% | 0.01% | -28.6% |
Q4 2013 | $2,308,000 | -23.7% | 95,321 | +11.7% | 0.01% | -22.2% |
Q3 2013 | $3,025,000 | +129.3% | 85,371 | +1.0% | 0.01% | +125.0% |
Q2 2013 | $1,319,000 | – | 84,497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |